control group :placebo combined with anlotinib

2 trials

Sponsors

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine

Conditions

Non-small cell lung cancer

Early Phase 1

Efficacy and safety of Yifei Sanjie Recipe combined with anlotinib in the treatment of the second line or above IIIB-IVB non-small cell lung cancer patients: a pilot study

Active, not recruitingChiCTR2100047143

The First Affiliated Hospital of Guangzhou University of Traditional Chinese MedicineNon-small cell lung cancer

Start: 2021-06-06Updated: 2022-01-24

Efficacy and safety of Yifei Sanjie Recipe combined with anlotinib in the treatment of the second line or above IIIB-IVB non-small cell lung cancer patients: a pilot study

Active, not recruitingITMCTR2100004926

The First Affiliated Hospital of Guangzhou University of Traditional Chinese MedicineNon-small cell lung cancer

Start: 2021-06-06Updated: 2023-02-20

Related Papers

Yifei Sanjie Formula or Placebo With Anlotinib as Second-Line or Above Treatment for Metastatic Non-Small-Cell Lung Cancer: Study Protocol for a Double-Blind, Placebo-Controlled Randomized Pilot Study

Integrative Cancer Therapies2023-01-015 citations